Type 2 Diabetes

Hispanic adults with type 2 diabetes who attended a primary care clinic visit with a clinical pharmacist had a larger drop in HbA1c than those who received usual care, according to a study published in JAMA Network Open.

By performing physical activities in the mornings or afternoons, adults may lower their risk for developing type 2 diabetes. The same could not be said for those who exercise during the evening.

Tirzepatide induced greater HbA1c and body weight reductions vs. placebo than semaglutide for people with type 2 diabetes, according to data that will be presented at the European Association for the Study of Diabetes annual meeting.

In a hearing on September 21, an FDA committee rejected an implantable device capable of delivering a GLP-1 receptor agonist for adults with type 2 diabetes.

Adults diagnosed with latent autoimmune diabetes have similar morality risk and a higher risk for diabetic retinopathy than adults with type 2 diabetes, according to findings published in Diabetes Care.

Incidence rates for both type 1 and type 2 diabetes diagnoses increased among children and adolescents during the COVID-19 pandemic compared with 2016 to 2019, according to study findings published in JAMA Network Open.

Providers should focus more on using pharmacotherapies in addition to lifestyle intervention to prevent progression from prediabetes to type 2 diabetes, according to two researchers.

Physical activity during the morning and afternoon, but not during the evening, is associated with a lower risk for developing type 2 diabetes, according to findings published in Diabetologia.

Women with a history of gestational diabetes had a greater risk for subsequent mortality over 30 years compared with women who have been pregnant without gestational diabetes history, according to cohort study results published in JAMA Internal Medicine.

All-cause and cardiovascular mortality rates remained flat from 2006 to 2020 for people with type 1 diabetes who had a first-time myocardial infarction, despite mortality rates declining for type 2 diabetes, according to two presenters.